石四药集团(02005.HK)盐酸贝尼地平片取得药品生产注册批件

Group 1 - The company, Stone Four Pharmaceutical Group, has obtained the production registration approval from the National Medical Products Administration of China for Benidipine Hydrochloride Tablets (8mg) [1] - The product is classified as a Class 4 chemical drug and is considered to have passed the consistency evaluation [1] - Benidipine Hydrochloride Tablets are primarily used for the treatment of primary hypertension and angina pectoris [1] Group 2 - The raw material for Benidipine Hydrochloride has also been approved by the National Medical Products Administration for use in the marketed formulation [1]